- FDA Clears First Diagnostic Blood Test for AD
The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.
Medscape Medical News -
View
Fri, 16 May 2025 15:48:00 EDT
- New Hope for Better Bipolar Disorder Outcomes
Drs Stephen Strakowski, Andrew Nierenberg, and Peter Margolis discuss learning health systems.
Medscape Psychiatry -
View
Fri, 16 May 2025 14:02:20 EDT
- New ‘Real World’ Data on Lecanemab Side Effects
New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.
Medscape Medical News -
View
Fri, 16 May 2025 08:54:59 EDT
- New Weight-Loss Options Improve Cardiac Health
Weight loss can reverse the cardiovascular changes that take place in the heart, but will a new diet and exercise work, or is intervention necessary with bariatric surgery or GLP-1s?
Medscape Medical News -
View
Fri, 16 May 2025 08:26:51 EDT
- Certain HIV Meds Linked to Reduced Alzheimer’s Risk
The use of nucleoside reverse transcriptase inhibitors, but not other HIV medicines, is linked to a reduced risk for Alzheimer’s disease, new research shows.
Medscape Medical News -
View
Fri, 16 May 2025 05:27:24 EDT
- Hidden Risks of Antiepileptic Drugs in Pregnancy
Research highlights the potential risks of antiepileptic drugs during pregnancy, including teratogenicity and neurodevelopmental concerns.
Medscape Medical News -
View
Fri, 16 May 2025 04:25:32 EDT
- Novel Drug a Potential ‘Game-Changer’ for Narcolepsy
An investigational oral selective orexin receptor 2 agonist significantly improved measures of wakefulness, sleepiness, and cataplexy in adults with narcolepsy type 1.
Medscape Medical News -
View
Fri, 16 May 2025 02:49:24 EDT
- Thalamotomy ‘Sweet Spot’ for Essential Tremor Identified
Focusing magnetic resonance-guided focused ultrasound thalamotomy on a newly identified target in the brain could improve outcomes for essential tremor.
Medscape Medical News -
View
Fri, 16 May 2025 01:51:21 EDT
- New Data Back Crinecerfont in Congenital Adrenal Hyperplasia
In both children and adults, the drug allows for decreasing glucocorticoid dosing to physiological levels while still reducing androgen excess.
Medscape Medical News -
View
Thu, 15 May 2025 16:30:57 EDT
- Seeking a Perfect Risk-Benefit Balance in Treating VTE
Just 25 years ago, venous thromboembolism treatment regimens were primitive, writes Dr Holley. But two trials showed that apixaban and rivaroxaban are proving excellent options for tackling VTE.
Medscape Critical Care -
View
Thu, 15 May 2025 11:30:19 EDT
- FDA Okays Belzutifan for Pheochromocytoma or Paraganglioma
The approval makes belzutifan the first oral therapy for PPGL in the US market.
Medscape Medical News -
View
Thu, 15 May 2025 08:43:10 EDT
- FDA Approves Self-Administered Migraine Treatment
The U.S. Food and Drug Administration has approved Amneal Pharmaceuticals' self-administered migraine drug, giving way to a quick and more convenient treatment option for...
Reuters Health Information -
View
Thu, 15 May 2025 08:16:08 EDT
- Case Closed? Study Rules Out Mystery Neurologic Syndrome
“This is misdiagnosis, misdocumentation, and misinformation,” according to a researcher.
Medscape Medical News -
View
Thu, 15 May 2025 08:14:42 EDT
- The New Playbook for Ditching Dangerous Senior Meds
The new tool offers clinicians safer alternatives to high-risk medications flagged in the Beers Criteria.
Medscape Medical News -
View
Thu, 15 May 2025 04:22:37 EDT
- Brain Tissue Volume Predicts Late Stroke Treatment Success
Endovascular treatment for stroke in the late window is most beneficial in patients with penumbra volumes ≥ 120 mL, a study shows.
Medscape News UK -
View
Wed, 14 May 2025 08:00:00 EDT
- Stimulant Medications Don’t Cause Psychosis, New Study Finds
While children who took stimulant medications for ADHD were more likely to report experiencing a psychotic episode, the drugs did not appear to be the cause, researchers find.
Medscape Medical News -
View
Wed, 14 May 2025 02:22:24 EDT
- Managing Motion Sickness Onboard: Tips From a Ship’s Doctor
With limited space, limited staff, and potentially dozens of patients, shipboard physicians need fast, effective strategies to manage seasickness.
Medscape Medical News -
View
Tue, 13 May 2025 08:28:02 EDT
- MS Blood Biomarker Test Could Aid Care Decisions
Integrating a blood-based biomarker assay into clinical workflows can enhance decision-making in patients with multiple sclerosis, new real-world data suggest.
Medscape Medical News -
View
Tue, 13 May 2025 07:38:19 EDT
- Fremanezumab Shows Promise for Migraine Plus Depression
Fremanezumab is linked to a greater reduction in monthly migraine days and symptoms of depression in adults with both conditions, a new trial shows.
Medscape Medical News -
View
Tue, 13 May 2025 07:36:18 EDT
- Ubrogepant Eases Prodromal Migraine Symptoms
Ubrogepant, approved for acute treatment of migraine, may also reduce nonheadache symptoms that occur in the hours preceding migraine, new data suggest.
Medscape Medical News -
View
Tue, 13 May 2025 06:30:40 EDT